Nature's Sunshine Reports Strong Fourth Quarter and Full Year 2023 Financial Results
- Impressive Q4 2023 results for Nature’s Sunshine Products, Inc. (NATR) with net income more than tripling to $9 million and adjusted EBITDA up 21% to $9.7 million.
- Full year 2023 saw significant growth for NATR with net sales up 5.5% to $445.3 million and adjusted EBITDA increasing by 26% to $40.4 million.
- Gross margin improved to 72.1% in 2023 compared to 71.0% in 2022, driven by market mix improvements and price increases.
- Operating income in 2023 was $18.7 million, or 4.2% of net sales, compared to $16.3 million, or 3.8% of net sales, in 2022.
- NATR ended 2023 with cash and cash equivalents of $82.4 million and no outstanding debt.
- Outlook for 2024 shows expected net sales between $455 - $480 million and adjusted EBITDA between $42 - $48 million.
- Conference call scheduled for March 12th, 2024, to discuss Q4 and full year 2023 results.
- Replay of the conference call will be available until March 26, 2024, for those unable to attend.
- None.
Insights
The reported increase in GAAP net income and adjusted EBITDA for Nature's Sunshine Products, Inc. indicates a robust performance in the fourth quarter, with a more than tripling of net income and a 21% rise in adjusted EBITDA. Such a significant improvement in profitability metrics is likely to be received positively by investors, as it suggests operational efficiency and effective cost management. Furthermore, the company's gross margin improvement, despite inflationary pressures, is indicative of strong pricing power and cost-absorption capabilities. The no outstanding debt position coupled with a substantial cash reserve enhances the company's financial stability and provides flexibility for future investments or shareholder returns.
The growth in net sales, particularly the double-digit growth in North America, signifies robust market demand and effective expansion strategies. However, the decline in the European segment and the mixed results from Latin America and Other regions warrant a closer look to understand the underlying market dynamics. The company's focus on omnichannel customer growth engines could be a response to the increasing trend of digitalization in sales and marketing. Investors may view the company's strategic initiatives to leverage high-quality products and strong balance sheet as a sign of potential for sustainable growth.
The anticipated savings of $10 million in 2024 from gross margin initiatives reflects a proactive approach to cost optimization. The slight decrease in volume incentives as a percentage of net sales, despite the increase in net sales, demonstrates an effective balance between incentivizing sales volume and maintaining profit margins. The company's investment in digital growth and strategic initiatives, as indicated by the increase in SG&A expenses, is a strategic move that aligns with the broader industry trend towards digital transformation. The operational efficiencies achieved may provide the company with a competitive advantage in a market that is increasingly moving online.
- Fourth Quarter GAAP Net Income More Than Triples to
LEHI, Utah, March 12, 2024 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (“Nature’s Sunshine” and/or the “Company”), a leading natural health and wellness company of premium-quality herbal and nutritional products, reported financial results for the fourth quarter and full year ended December 31, 2023.
Fourth Quarter 2023 Financial Highlights vs. Same Year-Ago Quarter
- Net sales were up
6.0% to$108.9 million compared to$102.7 million (up5.6% in constant currency). - GAAP net income attributable to common shareholders up significantly to
$9.0 million , or$0.46 per diluted share, compared to$2.0 million , or$0.10 per diluted share. - Adjusted EBITDA up
21% to$9.7 million compared to$8.0 million .
Full Year 2023 Financial Highlights vs. 2022
- Net sales were up
5.5% to$445.3 million compared to$421.9 million (up7.3% in constant currency). - Gross margin increased 110 basis points to
72.1% compared to71.0% . - GAAP net income attributable to common shareholders up significantly to
$15.1 million , or$0.77 per diluted share, compared to a net loss of$0.4 million , or$(0.02) per diluted share. - Adjusted EBITDA up
26% to$40.4 million compared to$32.0 million .
Management Commentary
“The positive momentum in our business continued in the fourth quarter as sales increased
“We enter 2024 as a stronger organization that is executing at a high level against our sales and cost optimization initiatives, while continuing to drive incremental operating cash flow. As we move forward, we will look to build on our momentum by leveraging our high-quality products, our omnichannel customer growth engine, and our strong balance sheet to continue to drive sustainable profitable growth and expand shareholder value.”
Fourth Quarter 2023 Financial Results
| Net Sales by Operating Segment (Amounts in Thousands) | |||||||||||||||||
| Three Months Ended December 31, 2023 | Three Months Ended December 31, 2022 | Percent Change | Impact of Currency Exchange | Percent Change Excluding Impact of Currency | |||||||||||||
| Asia | $ | 47,813 | $ | 44,922 | 6.4 | % | $ | (421 | ) | 7.4 | % | ||||||
| Europe | 19,691 | 20,787 | (5.3 | ) | 613 | (8.2 | ) | ||||||||||
| North America | 35,706 | 31,647 | 12.8 | (12 | ) | 12.9 | |||||||||||
| Latin America and Other | 5,726 | 5,393 | 6.2 | 204 | 2.4 | ||||||||||||
| $ | 108,936 | $ | 102,749 | 6.0 | % | $ | 384 | 5.6 | % | ||||||||
Net sales in the fourth quarter of 2023 increased
Gross margin in the fourth quarter was
Volume incentives as a percentage of net sales were
Selling, general and administrative expenses (“SG&A”) in the fourth quarter were
Operating income in the fourth quarter was
Other income, net, in the fourth quarter of 2023 was
GAAP net income attributable to common shareholders was
Non-GAAP net income attributable to common shareholders was
Adjusted EBITDA in the fourth quarter increased to
Full Year 2023 Financial Results
| Net Sales by Operating Segment (Amounts in Thousands) | |||||||||||||||||
| Year Ended December 31, 2023 | Year Ended December 31, 2022 | Percent Change | Impact of Currency Exchange | Percent Change Excluding Impact of Currency | |||||||||||||
| Asia | $ | 201,251 | $ | 186,292 | 8.0 | % | $ | (8,773 | ) | 12.7 | % | ||||||
| Europe | 81,101 | 78,991 | 2.7 | 1,083 | 1.3 | ||||||||||||
| North America | 139,804 | 133,214 | 4.9 | (397 | ) | 5.2 | |||||||||||
| Latin America and Other | 23,164 | 23,413 | (1.1 | ) | 575 | (3.5 | ) | ||||||||||
| $ | 445,320 | $ | 421,910 | 5.5 | % | $ | (7,512 | ) | 7.3 | % | |||||||
Net sales in 2023 increased
Gross margin in 2023 increased 110 basis points to
Volume incentives as a percentage of net sales in 2023 were
SG&A in 2023 were
Operating income in 2023 was
Other income (loss), net, in 2023 was
GAAP net income (loss) attributable to common shareholders increased to
Non-GAAP net income attributable to common shareholders in 2023 was
Adjusted EBITDA in 2023 increased
Balance Sheet and Cash Flow
Net cash provided by operating activities was
Outlook
The Company expects full year 2024 net sales to range between
Conference Call
The Company will hold a conference call today at 5:00 p.m. Eastern time to discuss its fourth quarter and full year 2023 results.
Date: Tuesday, March 12th, 2024
Time: 5:00 p.m. Eastern time (3:00 p.m. Mountain time)
Toll-free dial-in number: 1-888-886-7786
International dial-in number: 1-416-764-8658
Conference ID: 14678754
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Group at 1-949-574-3860.
The conference call will be broadcast live and available for replay here and via the Events section of the Nature’s Sunshine website here.
A replay of the conference call will be available after 8:00 p.m. Eastern time on the same day through Wednesday, March 26, 2024.
Toll-free replay number: 1-844-512-2921
International replay number: 1-412-317-6671
Replay ID: 14678754
About Nature’s Sunshine Products
Nature’s Sunshine Products (Nasdaq: NATR), a leading natural health and wellness company, markets and distributes nutritional and personal care products in more than 40 countries. Nature’s Sunshine manufactures most of its products through its own state-of-the-art facilities to ensure its products continue to set the standard for the highest quality, safety and efficacy on the market today. Additional information about the company can be obtained at its website, www.naturessunshine.com.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements regarding the Company’s future business expectations, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to the Company’s objectives, plans, strategies and financial results. All statements (other than statements of historical fact) that address activities, events or developments that the Company intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. These statements are often characterized by terminology such as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and similar expressions, and are based on assumptions and assessments made by management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, including the following:
- extensive government regulations to which the Company’s products, business practices and manufacturing activities are subject;
- registration of products for sale in foreign markets, or difficulty or increased cost of importing products into foreign markets;
- legal challenges to the Company’s direct selling program or to the classification of its independent consultants;
- laws and regulations regarding direct selling may prohibit or restrict our ability to sell our products in some markets or require us to make changes to our business model in some markets;
- liabilities and obligations arising from improper activity by the Company’s independent consultants;
- product liability claims;
- impact of anti-bribery laws, including the U.S. Foreign Corrupt Practices Act;
- the Company’s ability to attract and retain independent consultants;
- the loss of one or more key independent consultants who have a significant sales network;
- potential for increased liability and compliance costs relating to the Company’s joint venture for operations in China with Fosun Industrial Co., Ltd.;
- the effect of fluctuating foreign exchange rates;
- failure of the Company’s independent consultants to comply with advertising laws;
- changes to the Company’s independent consultants compensation plans;
- geopolitical issues and conflicts;
- negative consequences resulting from difficult economic conditions, including the availability of liquidity or the willingness of the Company’s customers to purchase products;
- risks associated with the manufacturing of the Company’s products;
- supply chain disruptions, manufacturing interruptions or delays, or the failure to accurately forecast customer demand;
- failure to timely and effectively obtain shipments of products from our manufacturers and deliver products to our independent consultants and customers;
- world-wide slowdowns and delays related to supply chain, ingredient shortages and logistical challenges;
- uncertainties relating to the application of transfer pricing, duties, value-added taxes, and other tax regulations, and changes thereto;
- changes in tax laws, treaties or regulations, or their interpretation;
- failure to maintain an effective system of internal controls over financial reporting;
- cybersecurity threats and exposure to data loss;
- the storage, processing, and use of data, some of which contain personal information, are subject to complex and evolving privacy and data protection laws and regulations;
- reliance on information technology infrastructure; and
- the sufficiency of trademarks and other intellectual property rights.
These and other risks and uncertainties that could cause actual results to differ from predicted results are more fully detailed under the caption “Risk Factors” in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports filed on Form 10-Q.
All forward-looking statements speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in or incorporated by reference into this press release. Except as is required by law, the Company expressly disclaims any obligation to publicly release any revisions to forward-looking statements to reflect events after the date of this press release.
Non-GAAP Financial Measures
We have included information which has not been prepared in accordance with generally accepted accounting principles (GAAP), such as information concerning non-GAAP net income, adjusted EBITDA and net sales excluding the impact of foreign currency exchange fluctuations.
We utilize the non-GAAP measures of non-GAAP net income and adjusted EBITDA in the evaluation of our operations and believe that these measures are useful indicators of our ability to fund our business. These non-GAAP financial measures should not be considered as an alternative to, or more meaningful than, U.S. GAAP net income (loss) as an indicator of our operating performance.
Other companies may use the same or similarly named measures, but exclude different items, which may not provide investors with a comparable view of Nature’s Sunshine Products’ performance in relation to other companies. We have included a reconciliation of net income to adjusted EBITDA, the most comparable GAAP measure. We have also included a reconciliation of GAAP net income to non-GAAP net income and non-GAAP adjusted EPS, in the attached financial tables.
Net sales in local currency removes, from net sales in U.S. dollars, the impact of changes in exchange rates between the U.S. dollar and the functional currencies of our foreign subsidiaries. This is accomplished by translating the current period net sales into U.S. dollars using the same foreign currency exchange rates that were used to translate the net sales for the previous comparable period.
We believe presenting the impact of foreign currency fluctuations is useful to investors because it allows a more meaningful comparison of net sales of our foreign operations from period to period. Net sales excluding the impact of foreign currency fluctuations should not be considered in isolation or as an alternative to net sales in U.S. dollar measures that reflect current period exchange rates, or to other financial measures calculated and presented in accordance with U.S. GAAP.
With respect to our Adjusted EBITDA outlook for the full year 2024, a quantitative reconciliation to the corresponding GAAP information cannot be provided without unreasonable effort because of the inherent difficulty of accurately forecasting the occurrence and financial impact of the various adjusting items necessary for such reconciliation that have not yet occurred, are out of our control, or cannot be reasonably predicted, including but not limited to warrant liabilities and stock based compensation. For the same reasons, we are unable to assess the probable significance of the unavailable information, which could have a material impact on our future GAAP financial results.
Investor Relations:
Gateway Group
Cody Slach
1-949-574-3860
NATR@gateway-grp.com
| NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Amounts in thousands, except per share information) (Unaudited) | |||||||||||||||
| Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||
| Net sales | $ | 108,936 | $ | 102,749 | $ | 445,320 | $ | 421,910 | |||||||
| Cost of sales | (30,613 | ) | (28,587 | ) | (124,193 | ) | (122,150 | ) | |||||||
| Gross profit | 78,323 | 74,162 | 321,127 | 299,760 | |||||||||||
| Operating expenses: | |||||||||||||||
| Volume incentives | 32,760 | 31,136 | 135,320 | 130,377 | |||||||||||
| Selling, general and administrative | 39,855 | 38,844 | 167,058 | 153,125 | |||||||||||
| Operating income | 5,708 | 4,182 | 18,749 | 16,258 | |||||||||||
| Other income (loss), net | 1,953 | 1,994 | 1,453 | (1,043 | ) | ||||||||||
| Income before provision (benefit) for income taxes | 7,661 | 6,176 | 20,202 | 15,215 | |||||||||||
| Provision (benefit) for income taxes | (1,683 | ) | 4,092 | 3,786 | 14,665 | ||||||||||
| Net income | 9,344 | 2,084 | 16,416 | 550 | |||||||||||
| Net income attributable to noncontrolling interests | 382 | 130 | 1,340 | 940 | |||||||||||
| Net income (loss) attributable to common shareholders | $ | 8,962 | $ | 1,954 | $ | 15,076 | $ | (390 | ) | ||||||
| Basic and diluted net income (loss) per common share: | |||||||||||||||
| Basic earnings (loss) per share attributable to common shareholders | $ | 0.47 | $ | 0.10 | $ | 0.79 | $ | (0.02 | ) | ||||||
| Diluted earnings (loss) per share attributable to common shareholders | $ | 0.46 | $ | 0.10 | $ | 0.77 | $ | (0.02 | ) | ||||||
| Weighted-average basic common shares outstanding | 18,988 | 19,155 | 19,066 | 19,326 | |||||||||||
| Weighted-average diluted common shares outstanding | 19,395 | 19,299 | 19,466 | 19,326 | |||||||||||
| NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (Amounts in thousands) (Unaudited) | |||||||
| As of December 31, | 2023 | 2022 | |||||
| Assets | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 82,373 | $ | 60,032 | |||
| Accounts receivable, net of allowance for doubtful accounts of | 8,827 | 14,106 | |||||
| Inventories | 66,895 | 67,949 | |||||
| Prepaid expenses and other | 7,722 | 7,420 | |||||
| Total current assets | 165,817 | 149,507 | |||||
| Property, plant and equipment, net | 45,000 | 46,162 | |||||
| Operating lease right-of-use assets | 13,361 | 16,145 | |||||
| Restricted investment securities - trading | 747 | 702 | |||||
| Deferred income tax assets | 15,064 | 6,859 | |||||
| Other assets | 9,784 | 10,403 | |||||
| $ | 249,773 | $ | 229,778 | ||||
| Liabilities and Shareholders’ Equity | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 7,910 | $ | 6,349 | |||
| Accrued volume incentives and service fees | 22,922 | 21,830 | |||||
| Accrued liabilities | 33,162 | 25,591 | |||||
| Deferred revenue | 1,794 | 2,255 | |||||
| Current installments of long-term debt and revolving credit facility | — | 1,174 | |||||
| Income taxes payable | 6,418 | 4,117 | |||||
| Current portion of operating lease liabilities | 4,547 | 4,266 | |||||
| Total current liabilities | 76,753 | 65,582 | |||||
| Liability related to unrecognized tax benefits | 312 | 209 | |||||
| Long-term portion of operating lease liabilities | 10,376 | 13,745 | |||||
| Deferred compensation payable | 747 | 702 | |||||
| Long-term deferred income tax liabilities | 1,401 | 1,439 | |||||
| Other liabilities | 644 | 1,054 | |||||
| Total liabilities | 90,233 | 82,731 | |||||
| Shareholders’ equity: | |||||||
| Common stock, no par value; 50,000 shares authorized, 18,875 and 19,093 shares issued and outstanding as of December 31, 2023, and 2022, respectively | 119,694 | 121,583 | |||||
| Retained earnings | 49,711 | 34,635 | |||||
| Noncontrolling interests | 5,482 | 4,142 | |||||
| Accumulated other comprehensive loss | (15,347 | ) | (13,313 | ) | |||
| Total shareholders’ equity | 159,540 | 147,047 | |||||
| $ | 249,773 | $ | 229,778 | ||||
| NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Amounts in thousands) (Unaudited) | |||||||
| Year Ended December 31, | 2023 | 2022 | |||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||
| Net income | $ | 16,416 | $ | 550 | |||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
| Provision for doubtful accounts | 45 | 45 | |||||
| Depreciation and amortization | 11,816 | 11,025 | |||||
| Noncash lease expense | 4,417 | 4,657 | |||||
| Share-based compensation expense | 4,893 | 2,901 | |||||
| Loss on disposal or sale of property and equipment | — | 1,069 | |||||
| Deferred income taxes | (8,525 | ) | 6,603 | ||||
| Purchase of trading investment securities | — | (32 | ) | ||||
| Proceeds from sale of trading investment securities | 97 | 134 | |||||
| Realized and unrealized (gains) losses on investments | (140 | ) | 160 | ||||
| Foreign exchange (gains) losses | (970 | ) | 917 | ||||
| Changes in operating assets and liabilities: | |||||||
| Accounts receivable | 4,921 | (5,942 | ) | ||||
| Inventories | 995 | (8,841 | ) | ||||
| Prepaid expenses and other | (683 | ) | 552 | ||||
| Other assets | 679 | 159 | |||||
| Accounts payable | 1,422 | (2,803 | ) | ||||
| Accrued volume incentives and service fees | 1,242 | (329 | ) | ||||
| Accrued liabilities | 6,991 | (5,608 | ) | ||||
| Deferred revenue | (456 | ) | (1,235 | ) | |||
| Lease liabilities | (4,707 | ) | (4,654 | ) | |||
| Income taxes payable | 2,627 | 1,426 | |||||
| Liability related to unrecognized tax positions | 103 | 218 | |||||
| Deferred compensation payable | 43 | (262 | ) | ||||
| Net cash provided by operating activities | 41,226 | 710 | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||
| Purchases of property, plant and equipment | (10,478 | ) | (7,628 | ) | |||
| Net cash used in investing activities | (10,478 | ) | (7,628 | ) | |||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
| Proceeds from revolving credit facility | 16,294 | 45,005 | |||||
| Principal payments of revolving credit facility | (16,294 | ) | (45,005 | ) | |||
| Principal payments of long-term debt | (1,174 | ) | (1,244 | ) | |||
| Principal payments of borrowings from related party | — | (302 | ) | ||||
| Payments related to tax withholding for net-share settled equity awards | (385 | ) | (1,129 | ) | |||
| Repurchase of common stock | (6,397 | ) | (13,571 | ) | |||
| Net cash used in financing activities | (7,956 | ) | (16,246 | ) | |||
| Effect of exchange rates on cash and cash equivalents | (451 | ) | (2,988 | ) | |||
| Net increase (decrease) in cash and cash equivalents | 22,341 | (26,152 | ) | ||||
| Cash and cash equivalents at beginning of the year | 60,032 | 86,184 | |||||
| Cash and cash equivalents at end of the year | $ | 82,373 | $ | 60,032 | |||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | |||||||
| Cash paid for income taxes, net of refunds | $ | 9,264 | $ | 5,609 | |||
| Cash paid for interest | 539 | 264 | |||||
| NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA (Amounts in thousands) (Unaudited) | |||||||||||||||
| Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||
| Net income | $ | 9,344 | $ | 2,084 | $ | 16,416 | $ | 550 | |||||||
| Adjustments: | |||||||||||||||
| Depreciation and amortization | 3,053 | 2,913 | 11,816 | 11,025 | |||||||||||
| Share-based compensation expense | 1,103 | 967 | 4,893 | 2,901 | |||||||||||
| Other (income) loss, net* | (1,953 | ) | (1,994 | ) | (1,453 | ) | 1,043 | ||||||||
| Provision (benefit) for income taxes | (1,683 | ) | 4,092 | 3,786 | 14,665 | ||||||||||
| Other adjustments (1) | (135 | ) | (31 | ) | 4,963 | 1,846 | |||||||||
| Adjusted EBITDA | $ | 9,729 | $ | 8,031 | $ | 40,421 | $ | 32,030 | |||||||
| (1) Other adjustments | |||||||||||||||
| Impact of Russia/Ukraine war | $ | — | $ | (1,300 | ) | $ | — | $ | 1,000 | ||||||
| Loss on disposal of property and equipment | — | 1,069 | — | 1,069 | |||||||||||
| Restructuring and other related expenses | — | 200 | — | 587 | |||||||||||
| Charge related to Japan loss | (135 | ) | — | 5,712 | — | ||||||||||
| VAT refund | — | — | (749 | ) | (810 | ) | |||||||||
| Total adjustments | $ | (135 | ) | $ | (31 | ) | $ | 4,963 | $ | 1,846 | |||||
* Other (income) loss, net is primarily comprised of foreign exchange (gains) losses, interest income, and interest expense.
| NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES RECONCILIATION OF GAAP NET INCOME TO NON-GAAP NET INCOME and NON-GAAP ADJUSTED EPS (Amounts in thousands) (Unaudited) | |||||||||||||||
| Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||
| Net income | $ | 9,344 | $ | 2,084 | $ | 16,416 | $ | 550 | |||||||
| Adjustments: | |||||||||||||||
| Impact of Russia/Ukraine war | — | (1,300 | ) | — | 1,000 | ||||||||||
| Loss on disposal of property and equipment | — | 1,069 | — | 1,069 | |||||||||||
| Restructuring and other related expenses | — | 200 | — | 587 | |||||||||||
| Charge related to Japan loss | (135 | ) | — | 5,712 | — | ||||||||||
| VAT refund | — | — | (749 | ) | (810 | ) | |||||||||
| Tax impact of adjustments | 34 | 8 | (1,428 | ) | (664 | ) | |||||||||
| Total adjustments | (101 | ) | (23 | ) | 3,535 | 1,182 | |||||||||
| Non-GAAP net income | $ | 9,243 | $ | 2,061 | $ | 19,951 | $ | 1,732 | |||||||
| Reported net income (loss) attributable to common shareholders | $ | 8,962 | $ | 1,954 | $ | 15,076 | $ | (390 | ) | ||||||
| Total adjustments | (101 | ) | (23 | ) | 3,535 | 1,182 | |||||||||
| Non-GAAP net income attributable to common shareholders | $ | 8,861 | $ | 1,931 | $ | 18,611 | $ | 792 | |||||||
| Basic income (loss) per share, as reported | $ | 0.47 | $ | 0.10 | $ | 0.79 | $ | (0.02 | ) | ||||||
| Total adjustments, net of tax | (0.01 | ) | — | 0.19 | 0.06 | ||||||||||
| Basic income per share, as adjusted | $ | 0.46 | $ | 0.10 | $ | 0.98 | $ | 0.04 | |||||||
| Diluted income (loss) per share, as reported | $ | 0.46 | $ | 0.10 | $ | 0.77 | $ | (0.02 | ) | ||||||
| Total adjustments, net of tax | (0.01 | ) | — | 0.18 | 0.06 | ||||||||||
| Diluted income per share, as adjusted | $ | 0.45 | $ | 0.10 | $ | 0.95 | $ | 0.04 | |||||||
FAQ
What was Nature’s Sunshine Products, Inc.'s (NATR) net income in Q4 2023?
How much did adjusted EBITDA increase in Q4 2023 for NATR?
What was the percentage increase in net sales for NATR in 2023?
What was the gross margin for NATR in 2023?
What was the operating income for NATR in 2023?
How much cash and cash equivalents did NATR have at the end of 2023?
What is the expected range for net sales in 2024 for NATR?
When is the conference call scheduled to discuss NATR's Q4 and full year 2023 results?
